Coronary artery bypass grafting
SACRT 022
Phase 3 other completed
Quick answer
Coronary artery bypass grafting for Ischemic Heart Failure is a Phase 3 program (other) at Rhythm Pharmaceuticals Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Rhythm Pharmaceuticals Netherlands B.V.
- Indication
- Ischemic Heart Failure
- Phase
- Phase 3
- Modality
- other
- Status
- completed